000 | 00834 a2200229 4500 | ||
---|---|---|---|
005 | 20250515111445.0 | ||
264 | 0 | _c20080328 | |
008 | 200803s 0 0 eng d | ||
022 | _a1565-1088 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMany, A | |
245 | 0 | 0 |
_aPreventing death in catastrophic antiphospholipid syndrome. _h[electronic resource] |
260 |
_bThe Israel Medical Association journal : IMAJ _cJan 2008 |
||
300 |
_a93; author reply 93 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
650 | 0 | 4 |
_aAntiphospholipid Syndrome _xdiagnosis |
650 | 0 | 4 |
_aEnoxaparin _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInternational Normalized Ratio |
773 | 0 |
_tThe Israel Medical Association journal : IMAJ _gvol. 10 _gno. 1 _gp. 93; author reply 93 |
|
999 |
_c17804201 _d17804201 |